CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net Income (loss)	$ (171)	$ 1,525
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of deferred acquisition costs	16,440	19,445
Acquisition costs deferred	(18,009)	(23,028)
Realized investment gains, net	(70)	(30)
Unrealized losses on equity securities, net	2,177	7,562
Losses (earnings) from equity method investees	360	(241)
Compensation expense related to share awards	119	134
Provision for credit losses	26	0
Depreciation and amortization	652	890
Deferred income tax benefit	(3,121)	(1,819)
(Increase) decrease in receivables, net	(3,520)	1,076
Increase in insurance reserves and policyholder funds	9,771	854
(Decrease) increase in accounts payable and accrued expenses	(1,662)	1,008
Other, net	(370)	(923)
Net cash used in operating activities	2,622	6,453
Cash flows from investing activities:
Proceeds from investments sold	5,044	3,902
Proceeds from investments matured, called or redeemed	9,744	9,806
Investments purchased	(18,073)	(17,010)
Additions to property and equipment	(80)	(126)
Net cash used in investing activities	(3,365)	(3,428)
Cash flows from financing activities:
Payment of dividends on Series D preferred stock	(399)	(399)
Payment of dividends on common stock	(408)	(408)
Treasury stock acquired - net employee share-based compensation	(12)	(108)
Proceeds from revolving credit facility, net	1,000	2,000
Net cash provided by financing activities	181	1,085
Net (decrease) increase in cash	(562)	4,110
Cash and cash equivalents at beginning of year	28,863	24,753
Cash and cash equivalents at end of year	28,301	28,863
Supplemental cash flow information:
Cash paid for interest	3,227	1,794
Cash paid for income taxes	$ 2,582	$ 2,764